LLS News Network

News and Information from The Leukemia & Lymphoma Society

LLS, The Mark Foundation for Cancer Research and The Paul G. Alle...

(Rye Brook, NY, July 1, 2020) - Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field. The innovative Blood Cancer Discoveries Grant Program is designed to encourage researchers with deep experi...

LLS Announces Collaboration with the National Cancer Institute an...

June 17, 2020 (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG) to launch a global precision medicine clinical trial for children with acute leukemia. The three organizations share a commitment to address the urgent need for new, more precise and more effective treatments for children with canc...

Patient Groups Warn: Administration Policy Encourages Discriminat...

June 15, 2020 – Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions: “By finalizing ...

Engine Shop Announces New Fundraising Program Connecting Gaming C...

NEW YORK, June 16, 2020 ­­– Individuals and communities nationwide are tapping into their inner creativity and survival skills to pivot to a virtual way of living. A campaign developed by Engine Shop, a leading engagement marketing agency, will connect a community of generous gamers with the lifesaving work of The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer. The campaign ...

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: